Background: Nearly 3 million people worldwide are coinfected with HIV and HCV. Affordable
strategies for prevention are needed. We developed a novel vaccination regimen involving …

Person-centered HIV PrEP for cisgender women | Nature Medicine Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …

This economic evaluation aims to support policy-making on the combined use of pre-
exposure prophylaxis (PrEP) with HIV vaccines in development by evaluating the potential …

Promising multi-dose HIV vaccine regimens are being tested in trials in South Africa. We
estimated the potential epidemiological and economic impact of HIV vaccine campaigns …

Background RV144 is to date the only HIV vaccine trial to demonstrate efficacy, albeit rapidly
waning over time. The HVTN 702 trial is currently evaluating in South Africa a similar …

Pathogen populations can evolve in response to selective pressure from vaccine-induced
immune responses. For HIV, models predict that viral adaptation, either via strain …

Structural assumptions in infectious disease models, such as the choice of network or
compartmental model type or the inclusion of different types of heterogeneity across …

This article summarizes the known biological functions of the alternative cellular energy
(ACE) pathway. It has been proposed that this pathway is powered by a natural force called …

Introduction: Promising HIV vaccine candidates are steadily progressing through the clinical
trial pipeline. Once available, HIV vaccines will be an important complement but also …

Introduction Mozambique continues to have a significant burden of HIV. Developing
strategies to control the HIV epidemic remains a key priority for the Mozambican public …